Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia

Clinical trial NCT01907815 · TERMINATED

Trial details

NCT number: NCT01907815
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia

Start date: 2013-10-01
Primary completion: 2016-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.